NCT06978413

Brief Summary

The goal of the pragmatic study is to evaluate the effectiveness of a home-based telerehabilitation protocol for patients with post-stroke disabilities, compared to a home-based educational program. The main question it aims to answer is: Is home-based neuromotor and cognitive rehabilitation using digital tools more effective than a traditional educational program for improving static and dynamic balance in patients with subacute and chronic stroke? Researchers will compare the outcome (Berg Balance Scale) measured at baseline with the outcome after treatment to test its effectiveness.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable stroke

Timeline
3mo left

Started May 2025

Geographic Reach
1 country

13 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
May 2025Jul 2026

First Submitted

Initial submission to the registry

May 9, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 18, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

May 20, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Expected
Last Updated

May 30, 2025

Status Verified

April 1, 2025

Enrollment Period

12 months

First QC Date

May 9, 2025

Last Update Submit

May 26, 2025

Conditions

Keywords

rehabilitationtelerehabilitationdigital technologieshome-based

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in the Berg Balance Scale (BBS)

    The Berg Balance Scale (BBS) is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete. It does not include the assessment of gait.

    Baseline; within 7 days after the end of the 6-week observation/rehabilitation period

Secondary Outcomes (17)

  • Fugl-Meyer Assessment for the upper extremities - motor function

    Baseline; within 7 days after the end of the 6-week observation/rehabilitation period

  • Fugl-Meyer Assessment for the upper extremities - sensory function

    Baseline; within 7 days after the end of the 6-week observation/rehabilitation period

  • Fugl-Meyer Assessment for the lower extremities - motor function

    Baseline; within 7 days after the end of the 6-week observation/rehabilitation period

  • Fugl-Meyer Assessment for the lower extremities - sensory function

    Baseline; within 7 days after the end of the 6-week observation/rehabilitation period

  • Modified Rivermead Motricity Index

    Baseline; within 7 days after the end of the 6-week observation/rehabilitation period

  • +12 more secondary outcomes

Other Outcomes (13)

  • premorbid Modified Rankin Scale

    Baseline

  • Montreal Cognitive Assessment Scale

    Baseline

  • Timed Up and Go

    Baseline

  • +10 more other outcomes

Study Arms (2)

Treatment with Digital Tools

EXPERIMENTAL

The experimental treatment involves home-based telerehabilitation protocols utilizing digital tools. Patients will perform task-oriented activities aimed at improving balance through standing and/or seated exercises under both static and dynamic conditions. Exercise complexity will be progressively adapted and personalized based on the patient's performance, improvement trajectory, and instrumental feedback from the digital system. All devices must have a CE mark for medical devices and be used according to the manufacturer's specifications.

Other: Integrated Treatment with Digital Tools

Educational Program

ACTIVE COMPARATOR

Patients in the Control Group will follow a self-guided educational program supported by printed materials outlining daily living activities to be performed at home.

Other: Home-Based Educational Program

Interventions

Patients will undergo a 6-week remote telerehabilitation program. The recommended frequency of treatment is a minimum of 3 sessions per week, but patients may adjust the schedule in agreement with their assigned therapist. If a patient is unable to complete at least 18 sessions due to clinical reasons, they will be considered as a dropout. Moreover, one session per week will be conducted synchronously, with the therapist remotely supervising the patient's activities in real time, while the remaining sessions will be asynchronous, allowing the patient to complete the exercises independently.

Treatment with Digital Tools

Patients will be monitored over a six-week period through weekly phone calls to assess their progress and overall condition. Additionally, participants are required to maintain an activity diary to document their engagement with the prescribed activities.

Educational Program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of first ischemic or hemorrhagic stroke verified by Computed Axial Tomography or MRI.
  • Age greater than 18 years.
  • Latency since the event: a) greater than 3 months and less than or equal to 6 months; b) greater than 6 months and less than 24 months.
  • Ability to perform the Timed Up and Go Test.

You may not qualify if:

  • Unstable clinical conditions.
  • Behavioral/cognitive disorders that prevent adequate patient compliance with the study (severe cognitive impairment, Montreal Cognitive Assessment\<17.5).
  • Severe visual impairment that cannot be corrected by lenses, preventing the patient from performing treatment with digital instruments.
  • Refusal to sign informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

Fondazione Don Carlo Gnocchi, Centro Gala

Acerenza, Italy

NOT YET RECRUITING

IRCCS Istituti Clinici Scientifici Maugeri

Bari, Italy

NOT YET RECRUITING

IRCCS Ospedale Policlinico San Martino

Genova, Italy

NOT YET RECRUITING

COT, Cure Ortopediche Traumatologiche, Istituto Clinico Polispecialistico

Messina, Italy

NOT YET RECRUITING

Fondazione Don Carlo Gnocchi, IRCCS Santa Maria Nascente

Milan, Italy

NOT YET RECRUITING

IRCCS Istituti Clinici Scientifici Maugeri

Milan, Italy

NOT YET RECRUITING

IRCCS Istituti Clinici Scientifici Maugeri

Montescano, Italy

NOT YET RECRUITING

IRCCS Fondazione Mondino

Pavia, Italy

NOT YET RECRUITING

Fondazione Don Carlo Gnocchi, Centro Santa Maria della Provvidenza

Rome, Italy

RECRUITING

Fondazione Don Carlo Gnocchi, Centro Santa Maria al Mare

Salerno, Italy

NOT YET RECRUITING

Fondazione Don Carlo Gnocchi, Polo Specialistico Riabilitativo

Sant'Angelo dei Lombardi, Italy

NOT YET RECRUITING

IRCCS Istituti Clinici Scientifici Maugeri

Telese Terme, Italy

NOT YET RECRUITING

Fondazione Don Carlo Gnocchi, Polo specialistico riabilitativo

Tricarico, Italy

NOT YET RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Irene G Aprile, MD, PhD

    IRCCS Fondazione Don Carlo Gnocchi

    STUDY DIRECTOR
  • Christian Lunetta

    IRCCS Istituti Clinici Scientifici Maugeri

    PRINCIPAL INVESTIGATOR
  • Roberto De Icco

    IRCCS Fondazione Mondino

    PRINCIPAL INVESTIGATOR
  • Carlo Trompetto

    IRCCS Ospedale Policlinico San Martino

    PRINCIPAL INVESTIGATOR
  • Ennio Ferlazzo

    COT Istituto Clinico Polispecialistico

    PRINCIPAL INVESTIGATOR
  • Silvana Quaglini

    Università di Pavia

    PRINCIPAL INVESTIGATOR
  • Giuseppe Turchetti

    Università Sant'Anna di Pisa

    PRINCIPAL INVESTIGATOR
  • Leandro Pecchia

    Campus Bio-Medico University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Irene G Aprile, MD, PhD

CONTACT

Marco Germanotta, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2025

First Posted

May 18, 2025

Study Start

May 20, 2025

Primary Completion

May 1, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

May 30, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) that underlie the results reported in the publication will be shared.

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning six months after the publication, with no end date.
Access Criteria
Access will be provided to the general scientific community and any interested researchers, for any type of analysis or secondary research use. The data will be made available on a public data-sharing platform such as Zenodo, or Figshare.

Locations